US$ 24.21
tirzepatide heart Tirzepatide, initially approved for Type 2 diabetes and weight management, is emerging as a promising treatment for failure. Recent studies indicate that it not only reduces the risk of heart… UC Irvine researchers project cardiac
Description
Unintentional weight loss beyond that expected from Wegovy treatment, which could signal malignancy or other serious disease

10.1016/j.ebiom.2016.03.034 106
Treatment goals: Mounjaro may offer more significant weight loss for some people, but it might not be right for everyone

It works by activating two hormone receptorsGLP-1 and GIPhelping to regulate appetite, increase feelings of fullness, and decrease food intake

Let's dive into what the research actually shows

Feldman Journal of the Peripheral Nervous System.2025;[Epub] CrossRef Electrodiagnostic assessment of autonomic nervous system in diabetic autonomic neuropathy: Case series in 72 diabetes patients Suchitra Dube, Sandip M
